Preliminary Novel Analysis on Antimicrobial Properties of Concentrated Growth Factor against Bacteria-Induced Oral Diseases

被引:4
|
作者
Alauddin, Muhammad Syafiq [1 ]
Yusof, Nabilah Mohd [2 ]
Adnan, Aini Sufinah [2 ]
Said, Zulfahmi [3 ]
机构
[1] Univ Sains Islam Malaysia, Dept Conservat Dent & Prosthodont, Fac Dent, Kuala Lumpur, Malaysia
[2] Univ Sains Islam Malaysia, Fac Dent, Kuala Lumpur, Malaysia
[3] Univ Sains Islam Malaysia, Dept Basic Sci & Oral Biol, Fac Dent, Kuala Lumpur, Malaysia
关键词
antibiofilm; concentrated growth factor; oral pathogen; platelet-rich concentrate; antibacterial; STAPHYLOCOCCUS-AUREUS MRSA; INFECTIONS; PLATELETS;
D O I
10.1055/s-0041-1742121
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective Concentrated growth factor (CGF) is particularly gaining acceptance and popularity in regenerative dentistry. Nonetheless, there are no available studies showing its effect against microorganisms of oral cavity particularly in chronic oral disease-induced biofilms. This in vitro research was conducted to determine the antimicrobial effects of CGF against Staphylococcus aureus sp. ( S. aureus ) and Streptococcus mutans sp. ( S. mutans ). Materials and Methods Blood samples were obtained from a healthy volunteer. CGF was then prepared using specialized centrifugation equipment (Medifuge, Silfradent, Santa Sofia FC, Italy) and protocol. Antimicrobial activity of the CGF was observed and recorded on standard strains of S. aureus and S. mutans using a well diffusion method to determine the inhibition zone, broth microdilution to determine minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), and crystal violet assay for biofilm assessment, with chlorhexidine (CHX) 0.12% used as a positive control. Statistical analysis was then performed using one-way analysis of variance followed by Tukey Test post hoc analysis. Results It was observed that there was a presence of clear zones of inhibition around the CGF after 24hours of incubation. The mean diameter of the inhibition zone was 1.260.12nm and 1.20 +/- 0.06nm for S. aureus and S. mutans , respectively, with significance difference ( p <0.05) against the control group CHX 0.12%. The MIC values of the CGF against S. aureus and S. mutans were 47.9% and 34.17%, respectively, and the MBC values of the CGF against S. aureus and S. mutans were 100%. The viability and the ability in inhibiting the biofilm formation of S. mutans and S. aureus following treatment with CGF showed a reduction in the concentration-dependent manner as compared with the control group. Conclusion CGF possesses antimicrobial and antibiofilm activity against S. aureus and S. mutans .
引用
收藏
页码:901 / 910
页数:10
相关论文
共 49 条
  • [31] A novel antimicrobial peptide YS12 isolated from Bacillus velezensis CBSYS12 exerts anti-biofilm properties against drug-resistant bacteria
    Suchi, Suzia Aktar
    Nam, Kyung Bin
    Kim, Young Kyun
    Tarek, Hasan
    Yoo, Jin Cheol
    BIOPROCESS AND BIOSYSTEMS ENGINEERING, 2023, 46 (06) : 813 - 828
  • [32] A novel antimicrobial peptide YS12 isolated from Bacillus velezensis CBSYS12 exerts anti-biofilm properties against drug-resistant bacteria
    Suzia Aktar Suchi
    Kyung Bin Nam
    Young Kyun Kim
    Hasan Tarek
    Jin Cheol Yoo
    Bioprocess and Biosystems Engineering, 2023, 46 : 813 - 828
  • [33] Transforming growth factor-β1 inhibits non-pathogenic gram-negative bacteria-induced NF-κB recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation
    Haller, D
    Holt, L
    Kim, SC
    Schwabe, RF
    Sartor, RB
    Jobin, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) : 23851 - 23860
  • [34] MOLECULAR ANALYSIS OF c-Met-DRIVEN MEDULLOBLASTOMA CELL DISSEMINATION IDENTIFIED MAP4K4 AS A POTENTIAL NOVEL TARGET AGAINST GROWTH FACTOR-INDUCED METASTASIS
    Tripolitsioti, Dimitra
    Ma, Min
    Kumar, Karthiga
    Graehlert, Jasmin
    Egli, Katja
    Fiaschetti, Giulio
    Shalaby, Tarek
    Grotzer, Michael
    Baumgartner, Martin
    NEURO-ONCOLOGY, 2014, 16 : 137 - 137
  • [35] The Protective Effect of Novel Small Molecule Inhibitor (SKI2162) of Transforming Growth Factor-β Receptor against Radiation-induced Fibrosis
    Park, J.
    Lee, S.
    Ryu, S.
    Ryu, K.
    Kang, S.
    Park, E.
    Lee, H.
    Lee, J.
    Jung, H.
    Shin, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S719 - S719
  • [36] HIP/PAP C-type lectin with mitogenic and antiapoptotic properties: A novel growth factor that stimulates liver regeneration and protects against acute liver failure
    Lieu, HT
    Batteux, F
    Simon, MT
    Cortes, A
    Nicco, C
    Zavala, F
    Pauloin, A
    Tralhao, JG
    Soubrane, O
    Weill, B
    Brechot, C
    Christa, L
    JOURNAL OF HEPATOLOGY, 2005, 42 : 34 - 34
  • [37] Preliminary analysis of the antimicrobial activity of a novel surgical incise drape containing chlorhexidine gluconate against methicillin-resistant Staphylococcus aureus (MRSA) in an in vivo porcine, incisional-wound model
    Carty, Neal
    Leaper, David
    Perry, Larry
    Edmiston, Charles E., Jr.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2021, 49 (07) : 857 - 861
  • [38] Interim Analysis of Randomized Phase II Study of Recombinant Human Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy with Stem Cell Transplantation for Hematologic Malignancies
    Kim, Ji-Won
    Kim, Kyung Im
    Lee, Hyun Jung
    Kim, Byung-Su
    Bang, Soo-Mee
    Kim, Inho
    Oh, Jung Mi
    Yoon, Sung-Soo
    Lee, Jong Seok
    Park, Seonyang
    Kim, Byoung Kook
    BLOOD, 2010, 116 (21) : 399 - 399
  • [39] Ligand-based virtual screening, molecular docking, QSAR and pharmacophore analysis of quercetin-associated potential novel analogs against epidermal growth factor receptor
    Bommu, Uma Devi
    Konidala, Kranthi Kumar
    Pabbaraju, Neeraja
    Yeguvapalli, Suneetha
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2017, 37 (06) : 600 - 610
  • [40] A Novel Function of Endothelial Insulin-Like Growth Factor-1 Receptor-Regulation of Gastrointestinal Microbiota as a Defensive Mechanism against Obesity-Induced Metabolic Dysfunction
    Haywood, Natalie J.
    Luk, Cheukyau
    Futers, Timothy S.
    Reay, Melanie
    Makava, Natallia
    Skromna, Anna
    Cubbon, Richard
    Kearney, Mark
    DIABETES, 2024, 73